Samsung Bioepis Showcases Denosumab Data

Firm Publishes Phase I And Phase III Results For SB16 Proposed Biosimilar To Prolia

 
• By David Wallace
  
Samsung Bioepis has revealed trial results for its denosumab biosimilar

More from Biosimilars

More from Products